Bioceres Crop Solutions Corp (BIOX) fair value: what the stock is really worth
As of Oct 12, 2026: fair value of Bioceres Crop Solutions Corp $0.36, price $0.33, upside +9.8%, quality 40 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range $0.3226 – $16.00 · fair‑value band $0.1856 – $0.3635 · the $0.3310 price screens below the $0.3635 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.
Follow Bioceres Crop Solutions in your weekly email
Every Wednesday you see whether Bioceres Crop Solutions is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops.
Show more
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
Stock analysis
Bioceres Crop Solutions Corp (BIOX) currently trades at $0.3310, while our model-based Fair Value estimate is $0.3635, so the stock looks roughly fairly valued today (gap 8.9%).
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $0.3635 per share, and 4 of the 9 models we run sit above the $0.3310 price.
Bear case: the Multiples group reads lowest at $0.1026, and 5 of the 9 models stay below the price. Evidence for this calculation is low.
Scenario range: $0.1856 (bear) to $0.3635 (bull), the price of $0.3310 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 40/100 (below-average quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Bioceres Crop Solutions Corp reported revenue of $238M in FY2026 versus $328M in FY2022, a compound −7.8%/yr. Reported net income was −$230M in FY2026.
Key figures
Market cap $21.1M · P/S ratio 0.09 · EPS (TTM) $−0.7400 · Net margin −96.8% · Return on equity −28.1% · Return on assets (EBIT) 3.8% · Operating margin −16.0% · Revenue (TTM) $238M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (medium confidence).
What moves the price
The share trades about 84% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at 22% fair-value upside, at 10%, BIOX screens richer than that median.
Fair Value models
Bear $0.1856Fair Value $0.3635Bull $0.3635
Price $0.3310 · Upside +9.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.35/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−28.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−17.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.8%
Start year 2021 (pandemic). Over 10 years: +46.8% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+32.8%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
18.6% (2021) → 0.0% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
News mood ⓘNews mood, the average tone of recent news (90 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Neutral
Recent news coverage is roughly neutral, about typical for how stocks are covered.
Compare Bioceres Crop Solutions Corp with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 166 stocks
Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score40 · Bottom 25%
Fair Value upside+9.8% · Above median
Profitability
Return on assets−0.1% · Bottom 25%
Net margin (TTM)−19.7% · Bottom 25%
Operating margin (TTM)−16.0% · Bottom 25%
Growth and dividend
Revenue growth−23.4% · Bottom 25%
Balance sheet
Debt / equity0.98× · Highest 25%
Valuation Multiplesvs Agricultural Inputs median · lower = cheaper
P/B0.54× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Bioceres Crop Solutions Corp (BIOX) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of $0.3635 versus a price of $0.3310, about +10% upside (fairly valued).
What is the fair value of BIOX?
Our model-based fair value for Bioceres Crop Solutions Corp is $0.3635 (as of Oct 3, 2026), built from audited fundamentals. The current price: $0.3310.
What is the quality score of BIOX?
Bioceres Crop Solutions Corp has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bioceres Crop Solutions Corp (BIOX)?
Our model-based price target is the fair value of $0.3635 (as of Oct 3, 2026) from 9 valuation models. Cautious scenario $0.1856, optimistic scenario $0.3635. It is a calculation from audited fundamentals, not an analyst target.
What is the Bioceres Crop Solutions Corp stock forecast for 2026?
Our models put fair value at $0.3635, about +10% upside versus a price of $0.3310 (fairly valued). Cautious scenario $0.1856, optimistic scenario $0.3635. The calculation is refreshed regularly with new filings.
What is the revenue of Bioceres Crop Solutions Corp (BIOX)?
Bioceres Crop Solutions Corp reported trailing-twelve-month revenue of about $238M (latest available figure, as of Oct 3, 2026).
What is the intrinsic value of Bioceres Crop Solutions Corp (BIOX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bioceres Crop Solutions Corp it is $0.3635 per share (as of Oct 3, 2026), against a price of $0.3310. It is the blended result of 9 valuation models (cash flow, earnings, asset, dividend).
Is Bioceres Crop Solutions Corp stock overvalued or undervalued in 2026?
As of Oct 3, 2026, BIOX trades below its calculated fair value: price $0.3310, fair value $0.3635, a gap of about +10% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BIOX?
No. The price is what the market pays today ($0.3310); the fair value is what the company's own numbers justify ($0.3635). For Bioceres Crop Solutions Corp the two are $0.0325 per share apart. That gap is exactly why we show both numbers side by side.
How much is Bioceres Crop Solutions Corp worth?
The market values Bioceres Crop Solutions Corp at about $21.1M (market capitalisation, as of Oct 3, 2026). Per share that is $0.3310; our models calculate a fair value of $0.3635 per share.
What do the bullish and bearish scenarios say about BIOX?
Our models span a range for Bioceres Crop Solutions Corp: cautious scenario $0.1856, base $0.3635, optimistic $0.3635 per share (as of Oct 3, 2026, price $0.3310). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of BIOX?
The PEG ratio of Bioceres Crop Solutions Corp is 1.95 (P/E divided by earnings growth, as of Oct 3, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Bioceres Crop Solutions Corp (BIOX)?
Balance-sheet figures for Bioceres Crop Solutions Corp (as of Oct 3, 2026): return on equity −28.1%, debt of 0.98 per unit of equity. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is BIOX from its 52-week high?
Bioceres Crop Solutions Corp trades at $0.3310, about 84% below its 52-week high of $2.03 and 3% above the low of $0.3226 (as of Oct 12, 2026). Distance from the high says nothing about value: that is what the fair value of $0.3635 is for.
Which stocks are comparable to Bioceres Crop Solutions Corp?
From the same area (Basic Materials) we also value Corteva, Inc, Nutrien Ltd, Qinghai Salt Lake Industry Co, CF Industries Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bioceres Crop Solutions Corp stock attractive at the current price?
The data as of Oct 3, 2026: price $0.3310, calculated fair value $0.3635 (+10%), Quality Score 40/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BIOX calculated?
We run Bioceres Crop Solutions Corp through 9 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.3635, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.8 % above its aggregate fair value. Bioceres Crop Solutions Corp currently trades 9 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Bioceres Crop Solutions Corp (BIOX)?
The closing price on Oct 12, 2026 was $0.3310. Our model-based fair value is $0.3635, about +10% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Bioceres Crop Solutions Corp right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range ($0.1856 to $0.3635) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Bioceres Crop Solutions Corp
How large is the market capitalisation of Bioceres Crop Solutions Corp (BIOX)?
The market capitalisation of Bioceres Crop Solutions Corp is $21.1M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Bioceres Crop Solutions Corp (BIOX)?
The price-to-sales ratio of Bioceres Crop Solutions Corp is 0.09 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Bioceres Crop Solutions Corp (BIOX)?
Earnings per share at Bioceres Crop Solutions Corp are $−0.7400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Bioceres Crop Solutions Corp (BIOX)?
The net margin of Bioceres Crop Solutions Corp is −96.8% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Bioceres Crop Solutions Corp (BIOX)?
The return on equity (ROE) of Bioceres Crop Solutions Corp is −28.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Bioceres Crop Solutions Corp (BIOX)?
On an EBIT basis the return on assets of Bioceres Crop Solutions Corp is 3.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Bioceres Crop Solutions Corp (BIOX)?
The operating margin of Bioceres Crop Solutions Corp is −16.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Bioceres Crop Solutions Corp (BIOX)?
Revenue at Bioceres Crop Solutions Corp is growing −23.4% versus a year earlier (3y avg −17.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Bioceres Crop Solutions Corp (BIOX)?
Earnings per share at Bioceres Crop Solutions Corp are growing +34.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Bioceres Crop Solutions Corp (BIOX) generate?
The free cash flow of Bioceres Crop Solutions Corp is $35.3M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Bioceres Crop Solutions Corp (BIOX) carry?
The net debt of Bioceres Crop Solutions Corp is $226M (fiscal year 2026, ≈ 6.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Bioceres Crop Solutions Corp in the live analysis
One click puts Bioceres Crop Solutions Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.
Thin data
Oct 3, 2026